293 related articles for article (PubMed ID: 15983063)
1. Loss of C/EBP alpha cell cycle control increases myeloid progenitor proliferation and transforms the neutrophil granulocyte lineage.
Porse BT; Bryder D; Theilgaard-Mönch K; Hasemann MS; Anderson K; Damgaard I; Jacobsen SE; Nerlov C
J Exp Med; 2005 Jul; 202(1):85-96. PubMed ID: 15983063
[TBL] [Abstract][Full Text] [Related]
2. Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia.
Pabst T; Mueller BU; Zhang P; Radomska HS; Narravula S; Schnittger S; Behre G; Hiddemann W; Tenen DG
Nat Genet; 2001 Mar; 27(3):263-70. PubMed ID: 11242107
[TBL] [Abstract][Full Text] [Related]
3. C/EBPalphap30, a myeloid leukemia oncoprotein, limits G-CSF receptor expression but not terminal granulopoiesis via site-selective inhibition of C/EBP DNA binding.
Cleaves R; Wang QF; Friedman AD
Oncogene; 2004 Jan; 23(3):716-25. PubMed ID: 14737106
[TBL] [Abstract][Full Text] [Related]
4. LEF-1 is a decisive transcription factor in neutrophil granulopoiesis.
Skokowa J; Welte K
Ann N Y Acad Sci; 2007 Jun; 1106():143-51. PubMed ID: 17360796
[TBL] [Abstract][Full Text] [Related]
5. HoxB8 requires its Pbx-interaction motif to block differentiation of primary myeloid progenitors and of most cell line models of myeloid differentiation.
Knoepfler PS; Sykes DB; Pasillas M; Kamps MP
Oncogene; 2001 Sep; 20(39):5440-8. PubMed ID: 11571641
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of myeloid lineage conversion using mice expressing an inducible form of C/EBP alpha.
Fukuchi Y; Shibata F; Ito M; Goto-Koshino Y; Sotomaru Y; Ito M; Kitamura T; Nakajima H
EMBO J; 2006 Jul; 25(14):3398-410. PubMed ID: 16858416
[TBL] [Abstract][Full Text] [Related]
7. CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50.
Paz-Priel I; Cai DH; Wang D; Kowalski J; Blackford A; Liu H; Heckman CA; Gombart AF; Koeffler HP; Boxer LM; Friedman AD
Mol Cancer Res; 2005 Oct; 3(10):585-96. PubMed ID: 16254192
[TBL] [Abstract][Full Text] [Related]
8. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
Harada Y; Harada H
J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039
[TBL] [Abstract][Full Text] [Related]
9. Induction of granulocytic differentiation by 2 pathways.
Zhang P; Nelson E; Radomska HS; Iwasaki-Arai J; Akashi K; Friedman AD; Tenen DG
Blood; 2002 Jun; 99(12):4406-12. PubMed ID: 12036869
[TBL] [Abstract][Full Text] [Related]
10. C/EBPalpha in leukemogenesis: a matter of being in the right place with the right signals.
Castilla LH
Cancer Cell; 2008 Apr; 13(4):289-91. PubMed ID: 18394549
[TBL] [Abstract][Full Text] [Related]
11. p21Waf1 inhibits granulocytic differentiation of 32Dcl3 cells.
Ghanem L; Steinman RA
Leuk Res; 2006 Oct; 30(10):1285-92. PubMed ID: 16499966
[TBL] [Abstract][Full Text] [Related]
12. C/EBPbeta is required for 'emergency' granulopoiesis.
Hirai H; Zhang P; Dayaram T; Hetherington CJ; Mizuno S; Imanishi J; Akashi K; Tenen DG
Nat Immunol; 2006 Jul; 7(7):732-9. PubMed ID: 16751774
[TBL] [Abstract][Full Text] [Related]
13. Transcription activation function of C/EBPalpha is required for induction of granulocytic differentiation.
Keeshan K; Santilli G; Corradini F; Perrotti D; Calabretta B
Blood; 2003 Aug; 102(4):1267-75. PubMed ID: 12702500
[TBL] [Abstract][Full Text] [Related]
14. Capillary gel electrophoresis: a simple method for identification of mutations and polymorphisms in the CEBPA gene in patients with acute myeloid leukaemia.
Juhl-Christensen C; Bomberg M; Melsvik D; Hokland P; Nyvold CG
Eur J Haematol; 2008 Oct; 81(4):273-80. PubMed ID: 18616509
[TBL] [Abstract][Full Text] [Related]
15. Induction of CCAAT/enhancer binding protein-delta by cytokinins, but not by retinoic acid, during granulocytic differentiation of human myeloid leukaemia cells.
Ishii Y; Kasukabe T; Honma Y
Br J Haematol; 2005 Feb; 128(4):540-7. PubMed ID: 15686465
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional dysregulation during myeloid transformation in AML.
Pabst T; Mueller BU
Oncogene; 2007 Oct; 26(47):6829-37. PubMed ID: 17934489
[TBL] [Abstract][Full Text] [Related]
17. C/EBPalpha in leukemogenesis: identity and origin of the leukemia-initiating cell.
Schuster MB; Porse BT
Biofactors; 2009; 35(3):227-31. PubMed ID: 19322763
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional control of granulocyte and monocyte development.
Friedman AD
Oncogene; 2007 Oct; 26(47):6816-28. PubMed ID: 17934488
[TBL] [Abstract][Full Text] [Related]
19. The amino terminal and E2F interaction domains are critical for C/EBP alpha-mediated induction of granulopoietic development of hematopoietic cells.
D'Alo' F; Johansen LM; Nelson EA; Radomska HS; Evans EK; Zhang P; Nerlov C; Tenen DG
Blood; 2003 Nov; 102(9):3163-71. PubMed ID: 12869508
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha.
Zhang P; Iwasaki-Arai J; Iwasaki H; Fenyus ML; Dayaram T; Owens BM; Shigematsu H; Levantini E; Huettner CS; Lekstrom-Himes JA; Akashi K; Tenen DG
Immunity; 2004 Dec; 21(6):853-63. PubMed ID: 15589173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
